{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:45:44Z","timestamp":1790423144739,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.semarthrit.2020.06.009","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T19:29:09Z","timestamp":1593545349000},"page":"1081-1086","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort"],"prefix":"10.1016","volume":"50","author":[{"given":"L.","family":"Durcan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.009_bib0001","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.semarthrit.2012.01.001","article-title":"The role of complement in the antiphospholipid syndrome: a novel mechanism for pregnancy morbidity","volume":"42","author":"Samarkos","year":"2012","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.009_bib0002","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1084\/jem.200116116","article-title":"Complement C3 activation is required for antiphospholipid antibody-induced fetal loss","volume":"195","author":"Holers","year":"2002","journal-title":"J Exp Med"},{"issue":"14","key":"10.1016\/j.semarthrit.2020.06.009_bib0003","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1177\/0961203312458839","article-title":"C6 knock-out mice are protected from thrombophilia mediated by antiphospholipid antibodies","volume":"21","author":"Carrera-Mar\u00edn","year":"2012","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.009_bib0004","doi-asserted-by":"crossref","first-page":"e99386","DOI":"10.1371\/journal.pone.0099386","article-title":"Platelet activation and anti-phospholipid antibodies collaborate in the activation of the complement system on platelets in systemic lupus erythematosus","volume":"9","author":"Lood","year":"2014","journal-title":"PLoS ONE"},{"issue":"13","key":"10.1016\/j.semarthrit.2020.06.009_bib0005","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1177\/0961203312457210","article-title":"Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus\u2013a possible link to venous thrombosis?","volume":"21","author":"Lood","year":"2012","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.009_bib0006","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1002\/art.21627","article-title":"Platelet C4d is highly specific for systemic lupus erythematosus","volume":"54","author":"Navratil","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.009_bib0007","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/0961203308099974","article-title":"Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies","volume":"18","author":"Peerschke","year":"2009","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2020.06.009_bib0008","doi-asserted-by":"crossref","unstructured":"Petri MA, Conklin J, O'Malley T, Dervieux T. Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE 2019; 6:e000318.","DOI":"10.1136\/lupus-2019-000318"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.009_bib0009","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/art.1780350109","article-title":"Activation of the alternative complement pathway accompanies disease flares in systemic lupus erythematosus during pregnancy","volume":"35","author":"Buyon","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.009_bib0010","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A","article-title":"A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.semarthrit.2020.06.009_bib0011","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1191\/0961203304lu1080oa","article-title":"Hypocomplementemia in systemic lupus erythematosus and primary antiphospholipid syndrome: prevalence and clinical significance in 667 patients","volume":"13","author":"Ramos-Casals","year":"2004","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.009_bib0012","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.009_bib0013","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of the systemic lupus international collaborating clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.009_bib0014","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European league against rheumatism\/american college of rheumatology classification criteria for systemic lupus Erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.009_bib0015","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.009_bib0016","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.009_bib0017","first-page":"541","volume":"10","author":"Vitali","year":"1992","journal-title":"Clin Exp Rheumatol."},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.009_bib0018","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/rheumatology\/keh624","article-title":"BILAG 2004. Development and initial validation of an updated version of the British Isles Lupus Assessment Group's disease activity index for patients with systemic lupus erythematosus","volume":"44","author":"Isenberg","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.009_bib0019","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1191\/096120301678646146","article-title":"Reliability and validity of systemic lupus activity measure-revised (SLAM-R) for measuring clinical disease activity in systemic lupus erythematosus","volume":"10","author":"Bae","year":"2001","journal-title":"Lupus"},{"issue":"9","key":"10.1016\/j.semarthrit.2020.06.009_bib0020","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1136\/annrheumdis-2014-205287","article-title":"The complement system in systemic lupus erythematosus: an update","volume":"73","author":"Leffler","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"25","key":"10.1016\/j.semarthrit.2020.06.009_bib0021","doi-asserted-by":"crossref","first-page":"14869","DOI":"10.1073\/pnas.95.25.14869","article-title":"Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees","volume":"95","author":"Moser","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"15","key":"10.1016\/j.semarthrit.2020.06.009_bib0022","first-page":"1140","article-title":"Second of two parts","volume":"344","author":"Complement","year":"2001","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.009_bib0023","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1177\/0961203314547791","article-title":"Anti-C1q antibodies in systemic lupus erythematosus","volume":"24","author":"Orbai","year":"2015","journal-title":"Lupus"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.009_bib0024","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/art.1780400819","article-title":"Deposition of antibodies to the collagen-like region of C1q in renal glomeruli of patients with proliferative lupus glomerulonephritis","volume":"40","author":"Mannik","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.009_bib0025","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0002-9343(86)90250-0","article-title":"Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans","volume":"81","author":"Howard","year":"1986","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.semarthrit.2020.06.009_bib0026","first-page":"2063","article-title":"Serum complement determinations in patients with quiescent systemic lupus erythematosus","volume":"23","author":"Sullivan","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2020.06.009_bib0027","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.thromres.2017.06.014","article-title":"A novel 2-stage approach that detects complement activation in patients with antiphospholipid antibody syndrome","volume":"156","author":"Rand","year":"2017","journal-title":"Thromb Res"},{"issue":"1","key":"10.1016\/j.semarthrit.2020.06.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2019-000318","article-title":"Platelet-bound C4d, low C3 and lupus anticoagulant associate with thrombosis in SLE","volume":"6","author":"Petri","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.009_bib0029","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.009_bib0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/RHU.0000000000000290","article-title":"Eculizumab induces sustained remission in a patient with refractory primary catastrophic antiphospholipid syndrome","volume":"21","author":"Zikos","year":"2015","journal-title":"J Clin Rheumatol"},{"issue":"26","key":"10.1016\/j.semarthrit.2020.06.009_bib0031","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1097\/MD.0000000000000143","article-title":"Efficacy of eculizumab in a patient with immunoadsorption-dependent catastrophic antiphospholipid syndrome: a case report","volume":"93","author":"Kronbichler","year":"2014","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"10.1016\/j.semarthrit.2020.06.009_bib0032","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ajt.12540","article-title":"Eculizumab prevents recurrent antiphospholipid antibody syndrome and enables successful renal transplantation","volume":"14","author":"Lonze","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semarthrit.2020.06.009_bib0033","article-title":"36-year-old female with catastrophic antiphospholipid syndrome treated with eculizumab: a case report and review of literature","volume":"2014","author":"Strakhan","year":"2014","journal-title":"Case Rep Hematol"},{"issue":"8","key":"10.1016\/j.semarthrit.2020.06.009_bib0034","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1002\/art.34440","article-title":"Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab","volume":"64","author":"Shapira","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"18","key":"10.1016\/j.semarthrit.2020.06.009_bib0035","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJMc0910965","article-title":"Eculizumab and renal transplantation in a patient with CAPS","volume":"362","author":"Lonze","year":"2010","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.semarthrit.2020.06.009_bib0036","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1191\/0961203303lu397oa","article-title":"Activation of complement mediates antiphospholipid antibody-induced pregnancy loss","volume":"12","author":"Salmon","year":"2003","journal-title":"Lupus"},{"issue":"11","key":"10.1016\/j.semarthrit.2020.06.009_bib0037","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1177\/0961203310371154","article-title":"The complex nature of serum C3 and C4 as biomarkers of lupus renal flare","volume":"19","author":"Birmingham","year":"2010","journal-title":"Lupus"},{"issue":"5","key":"10.1016\/j.semarthrit.2020.06.009_bib0038","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.1780400506","article-title":"The reliability of the systemic lupus international collaborating clinics\/american college of rheumatology damage index in patients with systemic lupus erythematosus","volume":"40","author":"Gladman","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.semarthrit.2020.06.009_bib0039","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/01.md.0000224709.70133.f7","article-title":"Predictors of survival in systemic lupus erythematosus","volume":"85","author":"Kasitanon","year":"2006","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.semarthrit.2020.06.009_bib0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3899\/jrheum.081194","article-title":"Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus","volume":"36","author":"Danowski","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017220301888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:05:49Z","timestamp":1758733549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017220301888"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0049017220301888"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.009","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical and serological associations of hypocomplementemia in a longitudinal sle cohort","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2020.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}